These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3136563)

  • 1. Abrogation of mouse pancreatic islet allograft rejection by a four-day culture.
    La Rosa FG
    Transplantation; 1988 Aug; 46(2):330-3. PubMed ID: 3136563
    [No Abstract]   [Full Text] [Related]  

  • 2. Current status of experimental islet transplantation.
    Lafferty KJ; Prowse SJ; Simeonovic CJ; Hegre O; Chase HP
    Transplant Proc; 1984 Jun; 16(3):813-9. PubMed ID: 6428005
    [No Abstract]   [Full Text] [Related]  

  • 3. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
    Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulation of pancreatic islet cells in allotransplantation.
    Tze WJ; Tai J
    Transplant Proc; 1982 Dec; 14(4):714-23. PubMed ID: 6820204
    [No Abstract]   [Full Text] [Related]  

  • 5. Involvement of graft-derived interleukin-15 in islet allograft rejection in mice.
    Lewis EC; Weiler M; Tejman-Yarden N; Ziv N; Mazar J; Chaimovitz C; Douvdevani A
    Cytokine; 2006 Apr; 34(1-2):106-13. PubMed ID: 16723256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
    Isakov N; Bach FH
    J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Allogenic grafts of mouse thyroid after passage in culture or survival in embryonic extracts].
    Jeanmire-Zylberberg R
    C R Seances Soc Biol Fil; 1974; 168(6-7):714-8. PubMed ID: 4282036
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of antilymphocyte serum on crude pancreatic islet allograft survival.
    Gotoh M; Maki T; Satomi S; Porter J; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 1):576-7. PubMed ID: 3152704
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolongation of islet allograft survival by anti-CD45 antibody pretreatment.
    Shapiro ME; Liu M
    Transplant Proc; 1995 Feb; 27(1):613-4. PubMed ID: 7879119
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of intra-islet endothelial cells in islet allo-immunity.
    Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
    Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection.
    Li XC; Roy-Chaudhury P; Hancock WW; Manfro R; Zand MS; Li Y; Zheng XX; Nickerson PW; Steiger J; Malek TR; Strom TB
    J Immunol; 1998 Jul; 161(2):890-6. PubMed ID: 9670967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced expression of class II major histocompatibility complex antigens on thyroid but not pancreatic islet allografts following transfer of sensitized LYT2+ T cells.
    Warren HS; Simeonovic CJ; Allan W; Hume DA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):213. PubMed ID: 3152690
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of specific and nonspecific alloantigen stimulation on islet allograft survival.
    Gotoh M; Porter J; Kanai T; Monaco AP; Maki T
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2746-7. PubMed ID: 2468235
    [No Abstract]   [Full Text] [Related]  

  • 14. Consistent long-term allograft survival in murine pancreatic islet transplants without immunosuppression.
    Jain K; Cai BR; Patel S; Yang H; Smith BH; Suthanthiran M; Rubin AL
    Transplant Proc; 1994 Dec; 26(6):3492-3. PubMed ID: 7998243
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenic properties of fetal mouse proislets.
    Simeonovic CJ; Lafferty KJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):938-9. PubMed ID: 3152643
    [No Abstract]   [Full Text] [Related]  

  • 16. RS-61443 allows islet allografting and specific tolerance induction in adult mice.
    Hao L; Lafferty KJ; Allison AC; Eugui EM
    Transplant Proc; 1990 Apr; 22(2):876-9. PubMed ID: 2109426
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term culture of viable human pancreatic islets in pyruvate-rich medium.
    Rastellini C; Cicalese L; Zeevi A; Mattes C; Stanko RT; Starzl TE; Rao AS
    Transplant Proc; 1995 Dec; 27(6):3383-4. PubMed ID: 8540008
    [No Abstract]   [Full Text] [Related]  

  • 18. Lyt-2+ cells sensitized to graft alloantigens trigger the rejection of established cultured pancreatic islet allografts.
    Warren HS; Prowse SJ; Agostino M; Lafferty KJ
    Transplant Proc; 1984 Aug; 16(4):954-5. PubMed ID: 6431669
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural killer T-cells participate in rejection of islet allografts in the liver of mice.
    Toyofuku A; Yasunami Y; Nabeyama K; Nakano M; Satoh M; Matsuoka N; Ono J; Nakayama T; Taniguchi M; Tanaka M; Ikeda S
    Diabetes; 2006 Jan; 55(1):34-9. PubMed ID: 16380474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inosine improves islet xenograft survival in immunocompetent diabetic mice.
    Schneider S; Klein HH
    Eur J Med Res; 2005 Jul; 10(7):283-6. PubMed ID: 16055398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.